Is it a hangover, an adverse event or a side effect?

2024-03-26T14:26:33+00:00March 18th, 2024|

In the world of pharmacovigilance, an adverse event is broadly any untoward medical occurrence after taking a medicinal product which does not have a causal relationship to treatment. Jim Hall looks at whether you're suffering from a hangover, an adverse event or a side effect.

MHRA GPvP symposium

2024-03-07T13:47:49+00:00March 7th, 2024|

Our EEA QPPV Sharon Corbett shares her key takeaways from the MHRA Good Pharmacovigilance Practice (GPvP) symposium which offered a deep dive into GPvP inspection non-compliance, metrics and trends, regulatory updates, and hot topics in pharmacovigilance.

Pharmacovigilance Audits

2024-02-19T14:25:48+00:00February 23rd, 2024|

Pharmacovigilance audits are essential for maintaining regulatory compliance, safeguarding patient safety, ensuring product quality, driving continuous improvement, and preserving the reputation of pharmaceutical companies.

Pharmacovigilance Service Provider

2024-02-12T11:31:02+00:00February 14th, 2024|

Finding your perfect partner is never easy. They need to have similar interests and views, be lively and you need to get along. The trouble is when you’re looking for a pharmacovigilance service provider, there isn’t the chance to go on that first date, enjoy a meal and then leave knowing the outcome was either a positive one or glad that was over. So, how do you go about finding that partner and starting that all-important relationship?


2024-02-06T09:51:04+00:00February 7th, 2024|

The EMA has recently published a Q&A guide on the implementation of Regulation (EU) 203/1182 and the potential need by Marketing Authorisation Holders to prepare in advance any regulatory, labelling and/or supply changes required for its implementation to help ensure the continuous supply of the product.


2023-11-06T11:33:06+00:00November 6th, 2023|

November 6th marks the start of the eighth annual MedSafetyWeek. This year’s campaign led by the Medicines and Healthcare products Regulatory Agency (MHRA), is all about the power of reporting.

Medical information – A vital service

2023-10-17T09:48:13+01:00October 9th, 2023|

Medical Information or “scientific service” is a multi-dimensional role which encompasses a wide range of various tasks and can act as the first point of contact for the identification of important drug safety information such as adverse reactions and product quality complaints. Read how JensonR+ can provide an effective and efficient Medical Information service that you can rely on.

Don’t blindly follow your Sat Nav

2024-01-18T14:56:13+00:00July 6th, 2023|

Our Regulatory, Quality and Pharmacovigilance subject matter experts here at JensonR+ can help reset your Sat Nav and ensure clarity of route and navigate the potholes and high-cost toll roads to keep you on track.

UK QPPV and National Contact Person (NCP)

2024-04-08T09:37:53+01:00May 31st, 2023|

JensonR+ has an in-house team of pharmacovigilance experts and dedicated UK and EU QPPVs. Our pharmacovigilance team can also provide NCP services. Find out more on how our pharmacovigilance team can support you.

Sarah’s celebrating six months at JensonR+

2023-10-23T15:04:47+01:00May 26th, 2023|

It's been six months since Sarah Parsons, our Senior Medical Information and Pharmacovigilance Officer joined the JensonR+ team and we thought it would be interesting to have a catch up with her and see how her work life has evolved over the last 12 months.

Go to Top